Physician profile
Suzanne Brown
NPI 1649689449
$627.32
in general payments reported to CMS, 2019-2025
14 companies · $21.63 in 2025
The $21.63 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $167 · 2023: $196 · 2024: $18.40 · 2025: $21.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $211.12 | 2021-2022 | |
| Medtronic, INC. | $62.59 | 2022-2023 | Chameleon |
| Abbvie INC. | $59.46 | 2021-2023 | |
| Boston Scientific Corporation | $47.13 | 2023 | Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $45.08 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $39.30 | 2021-2022 | |
| Organogenesis INC. | $36.83 | 2023 | Puraply |
| Cardiovascular Systems INC. | $26.55 | 2021-2023 | Diamondback Peripheral |
| Kci USA, INC. | $19.25 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Siemens Medical Solutions USA, INC. | $18.40 | 2024 | Artis Pheno |
| Angiodynamics, INC. | $18.30 | 2022 | |
| Silk Road Medical, INC. | $16.44 | 2022 | |
| Lemaitre Vascular, INC. | $15.63 | 2023 | Artegraft Vascular Graft |
| E.R. Squibb & Sons, L.L.C. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.